Not only has the prevalence of COVID-19 been high among patients with Parkinson s disease, but there is also a high rate of related hospitalizations and mortality, a new meta-analysis shows.
More research suggests a link between COVID-19 infection and chronic cerebrovascular impairment, revealing decreases in both cerebral vasoreactivity and cerebral blood flow.
Physicians from the Infectiouse Diseases Society of America weighed in on the new bivalent vaccines, the use of mouse data, and the current state of the pandemic.